GAL and prostate carcinoma: Indeed, LNCaPCHase cells displayed a significant reduction in Gal-NAz signal as compared to wildtype cells (Fig. 5c, Supplementary Fig. S6b, c), reflecting that a large and adequate portion of GalNAc residues is CS incorporated in prostate cancer.